Pages that link to "Q54787534"

The following pages link to Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. (Q54787534):

Displaying 43 items.

• Efficacy and safety of sirolimus in lymphangioleiomyomatosis (Q24610039) (← links)
• Optimizing treatments for lymphangioleiomyomatosis (Q26865250) (← links)
• Management of lymphangioleiomyomatosis (Q28084725) (← links)
• Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis (Q28084975) (← links)
• Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition (Q28566030) (← links)
• mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in LAM pathogenesis (Q28751693) (← links)
• Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs (Q30411083) (← links)
• Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement (Q33637626) (← links)
• Diffuse Cystic Lung Disease. Part I. (Q33722950) (← links)
• Lymphangioleiomyomatosis and TSC2-/- cells (Q33904951) (← links)
• The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis (Q33905090) (← links)
• Involvement of lymphatics in lymphangioleiomyomatosis (Q33905141) (← links)
• Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene (Q34161676) (← links)
• The loss of tuberin promotes cell invasion through the ß-catenin pathway (Q34269014) (← links)
• Unusual causes of pneumothorax (Q34375358) (← links)
• The Role of Chemokines in Migration of Metastatic-like Lymphangioleiomyomatosis Cells (Q34496096) (← links)
• Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis (Q34535040) (← links)
• Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies (Q34536450) (← links)
• Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis (Q34560457) (← links)
• The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis (Q34569989) (← links)
• Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness (Q35689467) (← links)
• Lymphatic involvement in lymphangioleiomyomatosis (Q36083291) (← links)
• Doxycycline reduces the migration of tuberous sclerosis complex-2 null cells - effects on RhoA-GTPase and focal adhesion kinase (Q36232850) (← links)
• Lymphangioleiomyomatosis - a wolf in sheep's clothing. (Q36357766) (← links)
• Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation (Q36712182) (← links)
• Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm (Q36755080) (← links)
• Lymphangioleiomyomatosis and tuberous sclerosis complex (Q37137669) (← links)
• Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene (Q37149062) (← links)
• Integration of mTOR and estrogen-ERK2 signaling in lymphangioleiomyomatosis pathogenesis (Q37173102) (← links)
• Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model (Q37193373) (← links)
• EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS. (Q37397803) (← links)
• Interstitial lung diseases-can pathologists arrive at an etiology-based diagnosis? A critical update (Q38065960) (← links)
• Pivotal role of augmented αB-crystallin in tumor development induced by deficient TSC1/2 complex (Q38452625) (← links)
• Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer (Q38895095) (← links)
• Regional Sparing in an Oligemic Lung Segment Supports Hematogenous Spread as a Pathogenic Mechanism in Lymphangioleiomyomatosis. (Q42340242) (← links)
• In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor (Q42645301) (← links)
• Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways (Q44552007) (← links)
• Cystic Lung Disease in Genetic Syndromes with Deficient Tumor Suppressor Gene Function (Q47370738) (← links)
• Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management (Q48355779) (← links)
• Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors. (Q51779283) (← links)
• Recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation (Q79368703) (← links)
• Neutrophil elastase from myeloid cells promotes TSC2-null tumor growth (Q89655137) (← links)
• Lymphangioleiomyomatosis (Q94388750) (← links)